MergerLinks Header Logo

Submit Deal

Submit Deal

Announced

Triton Partners to acquire a majority stake of Atnahs.

Synopsis

Triton Partners agreed to acquire a majority stake of Atnahs, a specialty pharmaceutical business, focussed on the acquisition, development and marketing of mature branded medicines. Financial terms were not disclosed.

Principals

Atnahs Pharma

target

Atnahs Pharma

Triton Partners

bidder

Triton Partners

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Dealmakers (5)

Service Providers

Sort

Amit Patel

Amit Patel

ManagerManaging Director at ATNAHS PHARMA
Deal Bio
Total Deals
1/
Total Value
value n/a
Will Thompson

Will Thompson

Financial AdvisorHead of Healthcare EMEA at Barclays
Deal Bio
Total Deals
30/
Total Value
£20,625M
Thomas Cowen

Thomas Cowen

Financial AdvisorVice President at Barclays
Deal Bio
Total Deals
37/
Total Value
£17,361M
Peder Prahl

Peder Prahl

InvestorManaging Partner at TRITON PARTNERS
Deal Bio
Total Deals
68/
Total Value
£8,329M
Roger Johnson

Roger Johnson

LawyerPartner at Kirkland & Ellis
Deal Bio
Total Deals
40/
Total Value
£45,767M

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US